BioLargo Basic EPS 2010-2024 | BLGO
BioLargo basic eps from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| BioLargo Annual Basic EPS |
| 2023 |
$-0.02 |
| 2022 |
$-0.02 |
| 2021 |
$-0.03 |
| 2020 |
$-0.05 |
| 2019 |
$-0.08 |
| 2018 |
$-0.09 |
| 2017 |
$-0.10 |
| 2016 |
$-0.09 |
| 2015 |
$-0.06 |
| 2014 |
$-0.05 |
| 2013 |
$-0.04 |
| 2012 |
$-0.08 |
| 2011 |
$-0.07 |
| 2010 |
$-0.13 |
| 2009 |
$-0.37 |
| BioLargo Quarterly Basic EPS |
| 2024-09-30 |
$-0.00 |
| 2024-06-30 |
$-0.00 |
| 2024-03-31 |
$-0.00 |
| 2023-12-31 |
$-0.01 |
| 2023-09-30 |
$-0.00 |
| 2023-06-30 |
$-0.01 |
| 2023-03-31 |
$-0.00 |
| 2022-12-31 |
$-0.00 |
| 2022-09-30 |
$0.00 |
| 2022-06-30 |
$-0.01 |
| 2022-03-31 |
$-0.01 |
| 2021-12-31 |
|
| 2021-09-30 |
$-0.01 |
| 2021-06-30 |
$-0.01 |
| 2021-03-31 |
$-0.01 |
| 2020-12-31 |
$-0.02 |
| 2020-09-30 |
$-0.01 |
| 2020-06-30 |
$-0.01 |
| 2020-03-31 |
$-0.01 |
| 2019-12-31 |
$-0.03 |
| 2019-09-30 |
$-0.02 |
| 2019-06-30 |
$-0.01 |
| 2019-03-31 |
$-0.02 |
| 2018-12-31 |
$-0.02 |
| 2018-09-30 |
$-0.02 |
| 2018-06-30 |
$-0.03 |
| 2018-03-31 |
$-0.02 |
| 2017-12-31 |
$-0.03 |
| 2017-09-30 |
$-0.02 |
| 2017-06-30 |
$-0.03 |
| 2017-03-31 |
$-0.02 |
| 2016-12-31 |
$-0.02 |
| 2016-09-30 |
$-0.03 |
| 2016-06-30 |
$-0.02 |
| 2016-03-31 |
$-0.02 |
| 2015-12-31 |
$-0.01 |
| 2015-09-30 |
$-0.02 |
| 2015-06-30 |
$-0.02 |
| 2015-03-31 |
$-0.01 |
| 2014-12-31 |
$-0.02 |
| 2014-09-30 |
$-0.01 |
| 2014-06-30 |
$-0.01 |
| 2014-03-31 |
$-0.01 |
| 2013-12-31 |
$-0.01 |
| 2013-09-30 |
$-0.01 |
| 2013-06-30 |
$-0.01 |
| 2013-03-31 |
$-0.01 |
| 2012-12-31 |
$-0.02 |
| 2012-09-30 |
$-0.01 |
| 2012-06-30 |
$-0.03 |
| 2012-03-31 |
$-0.02 |
| 2011-12-31 |
$-0.01 |
| 2011-09-30 |
$-0.01 |
| 2011-06-30 |
$-0.02 |
| 2011-03-31 |
$-0.03 |
| 2010-12-31 |
$-0.02 |
| 2010-09-30 |
$-0.03 |
| 2010-06-30 |
$-0.03 |
| 2010-03-31 |
$-0.05 |
| 2009-12-31 |
$-0.25 |
| 2009-09-30 |
$-0.04 |
| 2009-06-30 |
$-0.04 |
| 2009-03-31 |
$-0.04 |
| Sector |
Industry |
Market Cap |
Revenue |
| Construction |
Engineering - Research & Development Services |
$0.078B |
$0.012B |
|
BioLargo Inc. is a cleantech and life sciences innovator and engineering services solution provider. The company's core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs. BioLargo Inc. is based in WESTMINSTER, CA.
|
